FDA Inspection 1112955 — Libby Laboratories, Inc.

Libby Laboratories, Inc. — FEI 2912388

The FDA completed an inspection of Libby Laboratories, Inc. on Nov 8, 2019 in Berkeley, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 8, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Berkeley, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.